epirubicin has been researched along with Budd-Chiari Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, F; Fan, QS; Liu, FY; Song, P; Wang, MQ; Wang, Y | 1 |
1 other study(ies) available for epirubicin and Budd-Chiari Syndrome
Article | Year |
---|---|
Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stents; Tomography, X-Ray Computed | 2013 |